Mei‐Zhu Hong

766 total citations
24 papers, 549 citations indexed

About

Mei‐Zhu Hong is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Mei‐Zhu Hong has authored 24 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Mei‐Zhu Hong's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (6 papers). Mei‐Zhu Hong is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (6 papers). Mei‐Zhu Hong collaborates with scholars based in China, Taiwan and United States. Mei‐Zhu Hong's co-authors include Jin‐Shui Pan, Jianlin Ren, Yandan Ren, Danyi Zeng, Kuangnan Fang, Xuan Dong, Wei-Ming Chen, Yanyan Cai, Jia You and Yueyong Zhu and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Mei‐Zhu Hong

21 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei‐Zhu Hong China	9	224	214	114	112	60	24	549
Sanae Hayashi Japan	13	155 0.7×	231 1.1×	96 0.8×	145 1.3×	24 0.4×	31	518
Olga A. Khomich Russia	5	142 0.6×	160 0.7×	130 1.1×	111 1.0×	24 0.4×	9	495
Yasmine Ibrahim Egypt	13	155 0.7×	140 0.7×	48 0.4×	133 1.2×	60 1.0×	26	601
Wei-Lun Tsai Taiwan	12	168 0.8×	147 0.7×	70 0.6×	50 0.4×	45 0.8×	14	462
Rajesh Kumar Dutta United States	14	271 1.2×	215 1.0×	66 0.6×	61 0.5×	37 0.6×	21	616
Wenjing Zai China	16	350 1.6×	251 1.2×	38 0.3×	121 1.1×	72 1.2×	26	712
Fuyuan Zhou China	17	253 1.1×	340 1.6×	42 0.4×	297 2.7×	76 1.3×	31	821
Hu Li China	12	181 0.8×	178 0.8×	33 0.3×	109 1.0×	38 0.6×	28	444
Emily O’Neill United States	7	145 0.6×	158 0.7×	47 0.4×	114 1.0×	78 1.3×	13	624
David Marais South Africa	11	129 0.6×	249 1.2×	62 0.5×	58 0.5×	27 0.5×	16	534

Countries citing papers authored by Mei‐Zhu Hong

Since Specialization

Citations

This map shows the geographic impact of Mei‐Zhu Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Zhu Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Zhu Hong more than expected).

Fields of papers citing papers by Mei‐Zhu Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Zhu Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Zhu Hong. The network helps show where Mei‐Zhu Hong may publish in the future.

Co-authorship network of co-authors of Mei‐Zhu Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Zhu Hong. A scholar is included among the top collaborators of Mei‐Zhu Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Zhu Hong. Mei‐Zhu Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Mei‐Zhu, et al.. (2025). Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(11). 3161–3183.

Dong, Xuan, Lili Gong, Mei‐Zhu Hong, & Jin‐Shui Pan. (2024). Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study. BMC Gastroenterology. 24(1). 1 indexed citations

Huang, Lingyi, et al.. (2024). A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI. Frontiers in Public Health. 12. 1437432–1437432. 3 indexed citations

Dong, Xuan, et al.. (2024). Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future. Translational Gastroenterology and Hepatology. 9. 33–33. 15 indexed citations

Chen, Zhijian, et al.. (2023). Global burden of common cancers attributable to metabolic risks from 1990 to 2019. Med. 4(3). 168–181.e3. 15 indexed citations

Hong, Mei‐Zhu, et al.. (2022). Different clinical features of children and adults in regional outbreak of Delta COVID-19. BMC Infectious Diseases. 22(1). 728–728. 3 indexed citations

Chen, Wei-Ming, Min Fu, Chengju Zhang, et al.. (2022). Deep Learning-Based Universal Expert-Level Recognizing Pathological Images of Hepatocellular Carcinoma and Beyond. Frontiers in Medicine. 9. 853261–853261. 4 indexed citations

Hong, Mei‐Zhu, et al.. (2022). Global burden of major gastrointestinal cancers and its association with socioeconomics, 1990–2019. Frontiers in Oncology. 12. 942035–942035. 19 indexed citations

Dong, Xuan, et al.. (2022). Liver chemistries in severe or non-severe cases of COVID-19: A systematic review and meta-analysis. World Journal of Hepatology. 14(12). 2012–2024. 3 indexed citations

10.

Zeng, Danyi, Su Lin, Xuan Dong, et al.. (2021). Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. Journal of Hepatology. 75(3). 547–556. 98 indexed citations

11.

Qin, Lei, Wenjun Wei, Hong Cai, et al.. (2021). Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy. Scientific Reports. 11(1). 3253–3253. 2 indexed citations

12.

Hong, Mei‐Zhu, Linglong Ye, Lixin Jin, et al.. (2017). Noninvasive scoring system for significant inflammation related to chronic hepatitis B. Scientific Reports. 7(1). 43752–43752. 4 indexed citations

13.

Hong, Mei‐Zhu, et al.. (2017). Ghrelin mimetic MK-677 alleviates amyloid beta-related pathology in 5XFAD mice, an animal model of Alzheimer’s disease. European Neuropsychopharmacology. 27. S1022–S1023.

14.

Ren, Yandan, Lixin Jin, Wenjun Wei, et al.. (2016). Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy. Hepatology. 65(5). 1765–1768. 129 indexed citations

15.

Hong, Mei‐Zhu, Wenqi Huang, Jinchao Xu, et al.. (2014). Enhanced HBsAg Synthesis Correlates with Increased Severity of Fibrosis in Chronic Hepatitis B Patients. PLoS ONE. 9(1). e87344–e87344. 14 indexed citations

16.

Hong, Mei‐Zhu, Guoliang Chen, Wenqi Huang, et al.. (2014). Liver Stiffness Measurement-Based Scoring System for Significant Inflammation Related to Chronic Hepatitis B. PLoS ONE. 9(10). e111641–e111641. 6 indexed citations

17.

Hong, Mei‐Zhu, et al.. (2012). Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance. World Journal of Hepatology. 4(12). 389–389. 1 indexed citations

18.

Pan, Jin‐Shui, Mei‐Zhu Hong, & Jianlin Ren. (2009). Reactive oxygen species: A double-edged sword in oncogenesis. World Journal of Gastroenterology. 15(14). 1702–1702. 191 indexed citations

19.

Pan, Jin‐Shui, Mei‐Zhu Hong, Qifeng Zhou, et al.. (2009). Integrated application of uniform design and least-squares support vector machines to transfection optimization. BMC Biotechnology. 9(1). 52–52. 6 indexed citations

20.

Hong, Mei‐Zhu, et al.. (1999). Antagonism of p53-dependent apoptosis by mitogen signals.. PubMed. 59(12). 2847–52. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact